Nectin-4 PET for predicting enfortumab vedotin dose-response in urothelial carcinoma
- Journal:
- Science Advances
- Published:
- Affiliations:
- 6
- Authors:
- 9
| Institutions | Authors | Share |
|---|---|---|
| Johns Hopkins Medicine (JHM), JHU, United States of America (USA) | 0.75 | |
| Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA) | 0.25 |